RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Historical Holders from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RIGL on Nasdaq
Shares outstanding
16,629,429
Price per share
$42.84
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
14,988,939
Total reported value
$424,669,287
% of total 13F portfolios
0%
Share change
+1,070,844
Value change
+$32,615,936
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
164
Price from insider filings
$18.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.5% +28% $28,894,960 +$6,937,840 1,516,000 +32% Armistice Capital, LLC 31 Mar 2025
BlackRock, Inc. 7.7% -22% $26,340,596 -$6,978,323 1,381,983 -21% BlackRock, Inc. 31 Mar 2025
Soleus Capital Master Fund, L.P. 3.7% -45% $12,327,056 -$8,850,562 658,145 -42% Soleus Capital Master Fund, L.P. 30 Jun 2025
MORGAN STANLEY 0.7% $3,297,817 116,406 Morgan Stanley 30 Sep 2025
Invesco Ltd. 0% $122,918 6,449 Invesco Ltd. 31 Dec 2024
As of 30 Sep 2025, RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) has 164 institutional shareholders filing 13F forms. They hold 14,988,939 shares. of 16,629,429 outstanding shares (90%) .

Top 25 institutional shareholders own 67% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 1,724,898 +6.1% 0% $48,866,361
VANGUARD GROUP INC 6.3% 1,043,123 -0.93% 0% $29,551,674
GOLDMAN SACHS GROUP INC 4.4% 737,035 +304% 0% $20,880,201
ARMISTICE CAPITAL, LLC 4.4% 724,000 -55% 0.64% $20,510,920
ACADIAN ASSET MANAGEMENT LLC 4.1% 685,718 +10% 0.03% $19,413,000
MARSHALL WACE, LLP 3.6% 601,333 +63% 0.02% $17,035,765
Capitolis Liquid Global Markets LLC 3.6% 591,553 0% 0.13% $16,758,696
STATE STREET CORP 3.3% 554,318 -7.6% 0% $15,703,829
RENAISSANCE TECHNOLOGIES LLC 2.9% 474,209 +101% 0.02% $13,434,341
GEODE CAPITAL MANAGEMENT, LLC 2.5% 423,723 +2% 0% $12,006,458
Qube Research & Technologies Ltd 2.2% 360,966 +111% 0.01% $10,226,167
Soleus Capital Management, L.P. 2% 330,010 -50% 0.5% $9,349,183
JANE STREET GROUP, LLC 1.9% 321,894 +1757% 0.01% $9,119,257
D. E. Shaw & Co., Inc. 1.8% 306,489 0.01% $8,682,833
Hillsdale Investment Management Inc. 1.7% 284,394 +8.5% 0.24% $8,056,882
JANUS HENDERSON GROUP PLC 1.4% 230,722 0% $6,536,354
Connor, Clark & Lunn Investment Management Ltd. 1.4% 228,395 +54% 0.02% $6,470,430
CM Management, LLC 1.4% 225,000 -10% 5.3% $6,374,250
TWO SIGMA INVESTMENTS, LP 1.3% 220,298 +475% 0.01% $6,241,042
GLOBEFLEX CAPITAL L P 1.3% 217,630 +30% 0.95% $6,165,458
DIMENSIONAL FUND ADVISORS LP 1.3% 209,387 +35% 0% $5,933,012
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 186,326 +748% 0% $5,278,616
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 179,808 +132% 0% $5,093,961
Squarepoint Ops LLC 1% 172,638 +377% 0.01% $4,890,835
Trexquant Investment LP 1% 167,118 0.05% $4,734,453

Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 13,715 $587,561 -$299,481 $42.84 3
2025 Q3 14,988,939 $424,669,287 +$32,615,936 $28.33 164
2025 Q2 13,883,445 $260,032,689 +$336,299 $18.73 121
2025 Q1 13,902,025 $250,095,419 +$32,047,743 $17.99 118
2024 Q4 12,067,467 $202,977,408 +$2,514,731 $16.82 114
2024 Q3 11,904,852 $192,606,131 +$27,253,219 $16.18 87
2024 Q2 10,378,502 $85,309,593 +$85,148,446 $8.22 80